Furthermore, Chen et al. [38] showed that anticancer effects of HDACis in different tumour cell models closely depend on their ability to dissociate cytosolic HDAC-PP1 complexes and permit the free active PP1 to inhibit the AKT downstream signal. The gene discussed is HDAC9; the disease is neoplasm.